JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXRT
1876
NexPoint Residential Trust
NXRT
$631M
| $13.1M | ﹤0.01% |
209,105
+26,986
| +15% | +$2.05M |
|
|
BBSA
1877
DELISTED
JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF
BBSA
| $13M | ﹤0.01% |
271,113
-1,128
| -0.4% | -$54.4K |
|
|
GBT
1878
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $13M | ﹤0.01% |
406,113
+220,883
| +119% | +$6.47M |
|
|
SWTX
1879
DELISTED
SpringWorks Therapeutics
SWTX
| $13M | ﹤0.01% |
526,829
+442,164
| +522% | +$16.2M |
|
1880
Zillow
Z
$7.48B
| $13M | ﹤0.01% |
408,492
+247,288
| +153% | +$9.93M |
|
1881
GFL Environmental
GFL
$14.7B
| $13M | ﹤0.01% |
502,538
+28,425
| +6% | +$843K |
|
|
TXNM
1882
TXNM Energy Inc
TXNM
$5.91B
| $12.9M | ﹤0.01% |
269,712
-42,273
| -14% | -$1.98M |
|
1883
PUT
Synchrony
SYF
$25.8B
| $12.8M | ﹤0.01% |
+465,100
| New | +$16.1M |
|
|
X
1884
DELISTED
US Steel
X
| $12.8M | ﹤0.01% |
717,256
-308,992
| -30% | -$8.45M |
|
1885
Navient
NAVI
$829M
| $12.8M | ﹤0.01% |
916,172
-157,738
| -15% | -$2.45M |
|
1886
Community Bank
CBU
$3.43B
| $12.8M | ﹤0.01% |
202,491
+60,738
| +43% | +$3.98M |
|
1887
Adient
ADNT
$1.44B
| $12.8M | ﹤0.01% |
431,059
-7,253
| -2% | -$244K |
|
|
CONX
1888
DELISTED
CONX Corp. Class A Common Stock
CONX
| $12.8M | ﹤0.01% |
1,290,588
-149,884
| -10% | -$1.48M |
|
1889
New Mountain Finance
NMFC
$728M
| $12.7M | ﹤0.01% |
1,069,198
+99,209
| +10% | +$1.28M |
|
1890
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.39B
| $12.7M | ﹤0.01% |
263,312
-36,676
| -12% | -$1.78M |
|
1891
CALL
Bristol-Myers Squibb
BMY
$130B
| $12.7M | ﹤0.01% |
165,100
-626,400
| -79% | -$47.7M |
|
1892
Harley-Davidson
HOG
$2.7B
| $12.7M | ﹤0.01% |
399,609
+38,557
| +11% | +$1.37M |
|
1893
NOV
NOV
$7.45B
| $12.6M | ﹤0.01% |
743,145
-19,854
| -3% | -$374K |
|
1894
Greif
GEF
$5B
| $12.5M | ﹤0.01% |
200,955
-76,606
| -28% | -$4.68M |
|
1895
Penske Automotive Group
PAG
$14.3B
| $12.5M | ﹤0.01% |
119,729
-542
| -0.5% | -$58.1K |
|
|
DAY
1896
DELISTED
Dayforce
DAY
| $12.5M | ﹤0.01% |
266,141
-4,581,689
| -95% | -$254M |
|
|
PCPC
1897
DELISTED
Periphas Capital Partnering Corporation
PCPC
| $12.5M | ﹤0.01% |
511,036
+311,436
| +156% | +$7.64M |
|
1898
Delek US
DK
$4.12B
| $12.5M | ﹤0.01% |
482,337
-362,470
| -43% | -$9.78M |
|
1899
Skywest
SKYW
$4.16B
| $12.5M | ﹤0.01% |
586,296
+53,574
| +10% | +$1.41M |
|
1900
CALL
Coca-Cola
KO
$373B
| $12.5M | ﹤0.01% |
198,000
+65,600
| +50% | +$4.16M |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.